Introduction
Many factors influence recovery after surgery. The purpose of enhanced recovery after surgery programs is to facilitate recovery and reduce recovery time. The multimodal enhanced recovery after surgery (ERAS) concept includes a variety of medical and non-medical components that contribute to improving the postoperative recovery. [1] [2] [3] The program recommend the use of minimal invasive surgery when possible because of the clinical benefits. Randomized trials and a meta-analysis comparing laparoscopy with laparotomy in treating women with endometrial cancer have shown a lower rate of complications and shorter hospital stay in the laparoscopy group although none of the included trials were conducted in enhanced recovery after surgery programs. 4, 5 The majority of women with endometrial cancer continued to be treated by laparotomy until the introduction of the robotic technology. 6 Although the robotic system (Da Vinci®, Intuitive Surgical Systems, Sunnyvale, California) seems to be clinically effective, controversies have arisen about the benefits of the technique in relation to the increased costs.
Randomized trials using enhanced recovery after surgery are still required in order to quantify the benefits on perioperative outcome and risks associated with robotic surgery to draw definitive conclusions about the technique compared with open surgery. 7, 8 Only a few randomized trials have recently been published comparing robotic and abdominal surgery in endometrial cancer. 9, 10 When comparing surgical interventions it is important to keep all other perioperative factors similar in the groups and to use the best evidence-based methods for preventing and treating all perioperative discomfort.
The aims of this open, randomized controlled trial were to determine as primary outcome whether women with low-risk endometrial cancer operated with robotic hysterectomy in an enhanced recovery after surgery program had a faster postoperative recovery measured by patient-reported health-related quality of life, and as secondary outcomes, whether they had fewer postoperative symptoms, lower analgesic consumption and shorter hospitalization than women operated with abdominal hysterectomy.
Material and methods
A prospective open randomized controlled study of women with low-risk endometrial cancer, comparing robotic and abdominal hysterectomy in an enhanced recovery after surgery program was undertaken at the Department of Obstetrics and Gynecology at the University Hospital in Linköping, Sweden.
Women admitted for surgical treatment of stage I, endometrial cancer (endometrioid adenocarcinoma, grade 1 and 2) and scheduled for hysterectomy, bilateral salpingooophorectomy with peritoneal washings between February 2012 and May 2016 were asked to participate in the study. Additional medical inclusion criteria were: women ≥ 18 years of age, speaking Swedish fluently, with WHO-performance status ≤ 2. Exclusion criteria were: laparoscopic approach not considered suitable; a planned midline incision; more extensive surgery than hysterectomy and bilateral salpingo-oophorectomy was planned; any condition that excluded the woman from having intrathecal morphine analgesia; immunosuppressive medication; physically disabled; severe psychiatric or mental disorder.
The web program SISA (http://home.clara.net/sisa/randmiz.htm) generated a balanced randomization with sequences into blocks of ten with an allocation ratio 1:1 to robotic or abdominal hysterectomy. The woman was informed about the allocated method after signing an informed consent The participants had routine preoperative evaluation 11 and received identical information about the care and perioperative advice according to the enhanced recovery after surgery program.
Prior to the general anesthesia the women received an intrathecal combination of bupivacaine 20 mg and morphine 0.2 mg (women older than 70 years bupivacaine 15 mg and morphine 0.1 mg). The general anesthesia was standardized: induction with fentanyl and propofol, intubation facilitated with rocuronium and maintenance with sevoflurane. To prevent hypothermia, insufflation of heated CO2 was used in the robotic surgery. In the laparotomy group a hot air blanket was applied to the upper part of the body. Local anesthetic was injected in the area of the skin incision in both groups.
The abdominal hysterectomy was conducted through a transverse lower abdominal skin incision. The robotic hysterectomy was performed with four robotic ports and three robotic arms using the da Vinci ® , Surgery System. In both groups a bipolar vessel sealing device was used. Preoperatively the women received a single dose prophylactic antibiotic and routine thrombosis prophylaxis. All operations were performed by gynecological oncology surgeons; one skilled robotic surgeon operated robotically and six surgeons performed the abdominal surgery. The robotic gynecological surgery was introduced in our hospital 2010. The access to robotic surgery was restricted to one day per week outside holiday periods. Consequently, the number of women that could be subjected to robotic hysterectomy was limited.
The women received analgesics comprising oral paracetamol and diclofenac as long as needed. Rescue IV morphine, ketobemidon or oral oxycodone was given if necessary.
To quantify the amount of non-opioid analgesics given, the WHO-defined daily dose (DDD) methodology was used. 12 All opioids given, independent of administration route and including the intrathecal morphine, were registered and converted into an equivalent intravenously morphine dose. 13 The standardized criteria for discharge comprised that the woman was able to walk around, tolerated a normal diet, had sufficient pain relief with oral analgesics (≤4 on a numeric rating scale from 0 to 10), had voided spontaneously with less than 150 ml residual urine and showed no signs of mechanical bowel obstruction. These criteria were checked twice daily. The time of arrival at the operating theater and the time of discharge from the ward were registered. The length of hospital stay as the time to when the discharge criteria were met could be calculated.
Perioperative adverse events, in the text designated as complications, were registered during the hospital stay. After discharge, the women registered the analgesic consumption in a diary. The research nurse called the patient the day after discharge and then once weekly until the six-week outpatient visit to detect complications and to remind the participant to complete the questionnaires. At the six-week postoperative visit, the emphasis was on registration of complications and recovery.
Two validated generic forms, the EuroQol Group EQ-5D 14 and the Short Form-36, 15 were used to assess the health-related quality of life. The EQ-5D form was completed preoperatively, daily during the first week after surgery, and then once weekly until the sixweek postoperative visit. The Short Form-36 was completed twice, preoperatively and six weeks postoperatively.
The Swedish Postoperative Symptom Questionnaire, 16 a validated form including ratings of eight symptoms commonly reported after surgery: nausea, retching, headache, abdominal pain, tiredness, drowsiness, blurred vision and itching, was used to assess the postoperative symptoms. To estimate overall discomfort a postoperative symptom sum score of the eight symptoms was calculated (minimum sum score 8, maximum 32). The higher the sum score, the more discomfort the patient experienced. The participant was also asked to report the pain intensity in the surgical area at peak and on average on the particular day, rated on a seven-point Likert-type scale.
Anxiety, depression and pain sensitivity are factors that may influence postoperative recovery. In order to assess the balance of these conditions between the groups the participants completed the Hospital Anxiety and Depression Scale form and the Pain Sensitivity Questionnaire preoperatively after information of allocated treatment. 17, 18 
Statistical analyses
Sample size estimation was based on the primary outcome measure of quality of life, the EQ-5D health index. With an α = 0.05 and 1-β = 0.90, the sample size was estimated to be 50 women including a drop-out of 10%, based on the assumption that the EQ-5D health index differed by at least 0.2 units between the two groups, given the standard deviation of the EQ-5D index (0.2) obtained from previous published data from our institution. 19 Pearson Chi-square and Fisher's exact test were used to analyze categorical data.
Continuous data were analyzed by means of Mann-Whitney U-test. Repeated measures
ANOVA models were applied to analyze continuous data measured on more than two occasions. Since perioperative complications may influence recovery, the outcomes were adjusted for perioperative complications occurring before and after discharge. Consequently, it was necessary to divide the timing into two periods in the repeated measures ANOVA models; the first period from day 0 (dag of surgery) until day 4 when all women had been discharged, and the second period from day 5 until day 42. Kaplan-Meier survival analysis and the Cox proportional-hazard model were used to evaluate the occurrence of complications. The significance level was set at p < 0.05. All analyses were carried out according to intention-to-treat principles.
The Software STATISTICA 64 version 13.2 (Dell Software, 5 Polaris Way, Aliso Viejo, CA 92656, USA) was used to carry out the statistical analyses.
Ethical approval
The Regional Ethical Review Board in Linköping, Sweden approved the trial (Dnr 2011/108-31). The study was registered in ClinicalTrial.gov (NCT 01526655).
Results
The flowchart of the study participants is presented in Figure 1 . Twenty-four women randomized to abdominal and 25 to robotic hysterectomy completed the study.
The demographic and descriptive data are demonstrated in Table 1 and revealed a balanced distribution. The peri-and postoperative data including complications are shown in Table 2 , revealing no differences between the groups except for a significant shorter operation time for the abdominal group.
The EQ-5D index between the robotic and abdominal hysterectomy group did not differ significantly in the period from day 0 to day 4 ( Figure 2 ). The robotic hysterectomy group had a significantly faster recovery of the health-related quality of life in the period from day 5 to day 42 than the abdominal hysterectomy group, even when adjusted for complications. The women recovered to their preoperative level nearly two weeks earlier than the abdominal hysterectomy group.
The Short Form-36 showed that the groups had recovered evenly after six weeks (Table   3 ) except for the subscales of general health and social functioning, in robotic hysterectomy favor. When adjusted for complications on any occasion, only general health remained statistically significant (Mann-Whitney-U-test, p=0.04) in the group without complications (RH, n=17 and AH, n=12).
The women in the robotic group presented significantly fewer symptoms postoperatively according to the symptom sum score than the abdominal group after discharge when adjusted for complications (SDC Figure 3 ). The reported pain intensity at peak did not differ significantly in the period from day 0 to day 4 between the groups, but was significantly lower in the robotic group in the period from day 5 to day 42. However, after adjustment for complications the significance vanished. No such differences were seen between the groups for the reported pain intensity on average (SDC Figure 4 ) in these periods.
The consumption of opioids postoperatively was equally low in both groups and remained very low from day 1 onwards (SDC Figure 5 ). Likewise, the consumption of nonopioid analgesic revealed no significant differences between the groups.
There was no significant difference in the length of hospital stay from the time of arrival in the operation theater to discharge from the ward or in the time to meet the discharge criteria between the two groups ( Table 2 ). However, for the women who had no complications during hospital stay (RH, n=23 and AH, n=19) the time to meet the discharge criteria was significantly lower in the robotic group (median (range) 36 hours (30-60 hours) vs 36 hours (36-60 hours), Mann-Whitney U-test adjusted for ties, p=0.03).
None of the patients needed conversion of the robotic operation to laparotomy. No major complications occurred in the robotic group, whereas one patient was re-operated in the abdominal group due to vaginal vault bleeding. Minor complications were numerically more prevalent in the abdominal group, as shown in Table 2 . However, the Kaplan-Meier curve over time from discharge to occurrence of complications revealed no significant difference between the groups (SDC Figure 6 ). The perceived health-related quality of life showed a strong association with complications with lower EQ-5D health index in women with complications (SDC Figure 7) . In the multivariate model, perioperative complications occurring before discharge were a significant independent risk factor in the period from day 0 to day 4 for lower EQ-5D health index (p=0.01), higher consumption of opioids (p<0.01), higher pain intensity on average (p=0.03) and at peak (p=0.01). Complications occurring after discharge from day 5 to day 42 were likewise a significant independent risk factor for the corresponding variables with comparable p-values but also for a higher symptom sum score (p<0.01).
Discussion
This study showed that in an enhanced recovery after surgery setting robotic hysterectomy provided a faster recovery of the patient-reported health-related quality of life compared with abdominal hysterectomy in women with low-risk endometrial cancer. Six weeks postoperatively, the general health was significantly better for the women who had robotic hysterectomy without complications than for those who had abdominal. In this group, also hospital stay was shorter. week postoperative period, with noted benefits up to 12 weeks after surgery. This is in line with our trial. However the mean EQ-5D scores were not adjusted for postoperative complications and the surgery was not performed in an enhanced recovery after surgery setting. In our study no differences could be demonstrated between the groups in pain intensity, analgesic consumption and postoperative symptom score during hospital stay. This may indicate the positive effect of using the enhanced recovery after surgery protocol on postoperative recovery. 24 Length of stay and time to meet the discharge criteria was equally short in both groups showing a difference between medical discharge criteria and contextspecific social circumstances or demography prolonging hospital stay. It is difficult to compare hospital stay in this trial with others in endometrial cancer 8, 20 because of various study designs and differently defined hospital stay. Several studies, in conformity with ours, have shown longer operation times for robotic hysterectomy compared with abdominal. 6, 25 This seems to reflect learning curve effects not only for the surgeon but for the whole operating team. 26 Reports on learning curves for robotic hysterectomy differ widely from about ten to a large number of operations. 26, 27 The robotic surgeon in this study had performed more than 50 robotic procedures prior to the start of this trial. SDC Figure 6 . The Kaplan-Meier curve of the cumulative proportion of women without complications in relation to period from time of discharge to occurrence of the adverse event in the two groups. Comparison was performed by means of the Cox Proportional Hazard Model. Results presented as hazard ratio (HR) and 95% confidence interval (CI). 
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